Letter to the New York stem cell research program ethics board
By Jesse Reynolds and Susan Fogel
| 01. 21. 2009
Dear Members of the NYSTEM Ethics Board:
We are supporters of embryonic stem cell research who wish to express our deep concerns about your upcoming consideration of permitting payments to women to provide eggs for stem cell research. Multiple egg extraction poses risks to women's health without a clear and demonstrable scientific rationale, and allowing payments for eggs is contrary to the guidelines set by the National Academies of Science.
The extraction of eggs poses nontrivial health risks for the women. The drug most often used to shut down the ovaries, Lupron, can cause side effects, including severe joint pain, difficulty breathing, chest pain, depression, amnesia, hypertension, and asthma. The drugs used to hyperstimulate the ovaries can lead to Ovarian Hyperstimulation Syndrome, which in the most severe cases can lead to hospitalization and, rarely, death. The Institute of Medicine report, Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research, makes clear how little is known about the full risks of multiple egg extraction. In fact, the limited research has been done on infertile women, and therefore virtually...
Related Articles
By Azeen Ghorayshi and Sarah Kliff, The New York Times | 08.12.2024
An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos.
The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...
By Beth Duff-Brown, Stanford Institute for Economic Policy Research | 07.12.2024
The debate over in vitro fertilization (IVF) has become a hot-button policy and political issue, despite the medical procedure to help people become pregnant having been mainstream in the United States for nearly half a century.
The Alabama Supreme Court ...